New FDA-cleared AI tool could help predict if breast cancer will return
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"New FDA-cleared AI tool could help predict if breast cancer will return" is generating significant coverage in the Health category, with 8 articles from 8 distinct sources tracked by PULSE so far.
Outlets currently covering the story include WTKR, NBC 5 Chicago, News-Medical and MobiHealthNews. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 21d ago.
Quick answers
Why is "New FDA-cleared AI tool could help predict if breast cancer will return" trending?
Because 8 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- AI breast cancer tools show promise but still need work WTKR · 29d ago
- How a UChicago clinical trial using AI aims to personalize breast cancer treatment NBC 5 Chicago · 29d ago
- Supercomputer helps design more reliable AI for breast cancer diagnosis News-Medical · 29d ago
- SimBioSys gets FDA clearance for AI breast cancer recurrence risk tool MobiHealthNews · 29d ago
- New Approach Gauges Reliability of AI Breast Cancer Diagnosis Newswise · 29d ago
- FDA Clears TumorSight Risk, an MRI-Derived AI Recurrence Tool for HR+, HER2– Breast Cancer OncLive · 29d ago
- AI Mammography Advances Falter When Datasets Lack Diversity Bioengineer.org · 29d ago
- New FDA-cleared AI tool could help predict if breast cancer will return ABC News - Breaking News, Latest News and Videos · 29d ago
Topics
Related trends
‘Star Wars: A New Hope’ Set For IMAX 70mm Re-Release
Lucasfilm plans to unveil its future Star Wars movie slate at Star Wars Celebration in London next April, ending a theatrical drought since 2019's The Rise of Skywalker.
‘Y&R’s New Head Writers Promise ‘Sexy’ Next Chapter and Cast Surprises
New head writers for 'The Young and the Restless' preview explosive shifts, a sexy next chapter, and major cast surprises.
Treasury Rally Gets New Boost as Election Hammers the AI Trade
Treasury markets rally as a U.S. stock selloff and midterm election results impact investor focus.
New treatment may cure common hormonal cause of high blood pressure
A small study found that extended treatment with the aldosterone synthase inhibitor baxdrostat led to sustained blood pressure reduction for up to two years after patients stopped taking the drug.
The New York Times Doesn’t Understand AI’s Role in Suppressing Wages
Five business outlets report a wave of debate over how AI agents reshape management pay, headcount models and performance metrics across industries.
No clear winner after tight New Zealand general election
New Zealand faces weeks of political uncertainty after a knife-edge election left the National-led coalition with a projected one-seat majority and nearly 400,000 special votes still to be counted.